Arialys Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants (NCT06753955) | Arialys Therapeutics | 2025-02-25 |
| Phase 1 Study of ART5803 in Healthy Participants (NCT06575153) | Arialys Therapeutics | 2024-09-19 |
Track Arialys Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.